Effect of Clopidogrel on Midterm Graft Patency following Off-Pump Coronary Revascularization Surgery


  • Khalid Ibrahim
  • Ole Tjomsland
  • Dag Halvorsen
  • Rune Wiseth
  • Alexander Wahba
  • Asbjørn Karevold
  • Rune Haaverstad




Objective. The aim of the study was to evaluate the effect of clopidogrel on midterm graft patency following off-pump coronary revascularization surgery.

Design. Ninety-four consecutive patients who underwent off-pump coronary artery bypass grafting between 1997 and 2002 were studied (58 men, 36 women; 61.7 ± 9.8 years). The initial 36 patients (control group) received 75 to 160 mg acetyl salicylic acid (ASA) as an antiplatelet agent, whereas the consecutive 58 patients (clopidogrel group) received 75 mg clopidogrel postoperatively in addition to ASA. Intraoperatively, graft flow was assessed with transit-time flowmetry in all patients and the peripheral anastomoses were assessed with epicardial ultrasound in 28 patients. Sixty-two patients underwent angiography after a mean of 185 ± 92 days. A total of 82 grafts were evaluated angiographically. Grafts with TIMI flow 2 and 3 were assessed as patent.

Results. At angiographic follow-up, the overall graft patency rate was 84% (31/37) in the control group and 93% (42/45) in the clopidogrel group (P value was not significant [ns]). Graft patency rates for left internal mammary artery (LIMA) grafts were 92% (23/25) versus 96% (28/29) (ns), and for saphenous vein grafts were 66% (7/11) versus 87% (14/16) (ns), respectively.

Conclusion. The observed trend toward higher patency rates in patients treated with clopidogrel did not reach statistical significance. Further larger studies are necessary to confirm these preliminary results.


Arsan S, Koray AK, Cisbir SC. 2004. Clopidogrel in coronary artery surgery. Eur J of Cardiothorac Surg 26:869-71.nChu MWA, Wilson SR, Novick RJ, Stitt LW, Quantz MA. 2004. Does clopidogrel increase blood loss following coronary artery bypass surgery? Ann Thorac Surg 78:1536-41.nClarke TA, Waskell LA. 2003. Clopidogrel is metabolized by human cytochrome P450 3A and inhibited by atorvastatin. Drug Metab Dispos 31:53-9.nD'Ancona G, Karamanouikan HC, Salerno TA, Schmid S, Bergsland J. 1999. Flow measurement in coronary surgery. Heart Surg Forum 2:121-4.nDavid JL, Limet R. 1999. Antiplatelet activity of clopidogrel in coronary artery bypass graft surgery patients. Thromb Haemost 82:1417-21.nGrover FL, Johnson RR, Marshall G, Hammermeister KE. 1994. Impact of mammary grafts on coronary bypass operative mortality and morbidity. Department of Veterans Affairs Cardiac Surgeons. Ann Thorac Surg 57:559-68.nGurbuz AT, Zia AA, Vuran AC, Cui H, Aytac A. 2006. Postoperative clopidogrel improves mid-term outcome after off-pump coronary artery bypass graft surgery: a prospective study. Eur J Cardiothorac Surg 29:90-5.nHaaverstad R, Vitale N, Tjomsland O, Tromsdal A, Torp H, Samstad SO. 2002. Intraoperative color Doppler ultrasound assessment of LIMA-to-LAD anastomoses in off-pump coronary artery bypasses grafting. Ann Thorac Surg 74:S1390-4.nKapetanakis EI, Medlam DA, Boyce SW, et al. 2005. Administration prior to coronary artery bypasses grafting surgery: the cardiologist's panacea or the surgeon's headache? Eur Heart J 26:576-83.nKazaz H, Ustonsoy H, Celkan MA, Soydink S, Kayiran C, Bayar E. 2006. Midterm results of off-pump coronary artery bypass surgery in 136 patients: an angiographic control study. J Card Surg 21:6-10.nKim KB, Lim C, Lee C, et al. 2001. Off-pump coronary artery bypass may decrease the patency of saphenous vein grafts. Ann Thorac Surg 72:S1033-7.nLau WC, Gurbel PA, Watkins PB, et al. 2004. Contribution of hepatic cytochrome P450 3A4 metabolic activity to the phenomenon of clopidogrel resistance. Circulation 9:166-71.nLev EI, Patel RT, Kelly J, et al. 2006. Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance. J Am Coll Cardiol 47:27-33.nMishkel GJ, Aguirre FV, Ligon RW, Rocha-Singh KJ, Lucore CL. 1999. Clopidogrel as adjunctive antiplatelet therapy during coronary stenting. J Am Coll Cardiol 34:1884-90.nMuller I, Seyfarth M, Rudiger S, et al. 2001. Effects of a high dose of clopidogrel on platelet function in patients undergoing coronary stent placement. Heart 85:92-3.nNeubauer H, Gunesdogan B, Hanefeld C, Spiecker M, Mugge A. 2003. Lipophilic statins interfere with the inhibitory effects of clopidogrel on platelet function—a flow cytometry study. Eur Heart J 24:1744-9.nOnorati F, De Feo M, Cerasuolo F, et al. 2005. Myocardial protection in diabetics with left main stem disease: which is the best strategy? J Cardiovasc Surg 46:305-12.nParolai A, Alemanni F, Polvani G, et al. 2005. Meta-analysis of randomized trials comparing off-pump with on-pump coronary artery bypass graft patency. Ann Thorac Surg 80:2121-5.nPuskas JD, Williams WH, Mahoney EM, et al. 2004. Off-Pump vs conventional coronary artery bypass grafting: early and 1-year graft patency, cost, and quality-of-life outcomes. A randomized trial. JAMA 291:1841-9.nSavcic M, Hauert J, Bachmann F, Wyld PJ, Geudelin B, Cariou R. 1999. Clopidogrel loading dose regimens kinetic profile of pharmaco-dynamic response in healthy subjects. Semin Thromb Hemost 25 (suppl 2):15-9.nThebault JJ, Kieffer G, Cariou R. 1999. Single-dose pharmacodynamics of clopidogrel. Semin Thromb Hemost 25(suppl 2):3-8.nThe TIMI study group. 1984. The thrombolysis in myocardial infarction (TIMI) trial: phase I findings. N Engl J Med 33:523-30.nUnn KK, Kottke BA, Titus JL, Frye RL, Wallace RB, Brown AL. 1974. Pathologic changes in aortocoronary saphenous vein grafts. Am J Cardiol 34:526-32.nWong CK, French JK, Aylward P, et al. 2005. Patients with prolonged ischemic chest pain and presumed-new left bundle branch block have heterogeneous outcomes depending on the presence of ST-segment changes. J Am Coll Cardiol 46:29-38.nYusuf S, Phil D, Zhao F, et al. 2001. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 345:494-502.n



How to Cite

Ibrahim, K., Tjomsland, O., Halvorsen, D., Wiseth, R., Wahba, A., Karevold, A., & Haaverstad, R. (2006). Effect of Clopidogrel on Midterm Graft Patency following Off-Pump Coronary Revascularization Surgery. The Heart Surgery Forum, 9(6), E581-E856. https://doi.org/10.1532/HSF98.20061034